Former Chief Operating Officer · IRONWOOD PHARMACEUTICALS INC (IRWD)

William Huyett

FY2018 is the first fiscal year CompBrief holds for William Huyett as a named executive officer of IRONWOOD PHARMACEUTICALS; the record below is that year, complete. Every figure below is printed as the company filed it and cited to the filing it came from.

Total disclosed compensation, FY2018

$4,142,307

Salary $465,000Stock awards $1,090,298

2nd of 6 named executive officers at Ironwood Pharmaceuticals by FY2018 total.

6 named officers on file for IRONWOOD PHARMACEUTICALS, FY2018

William Huyett’s pay file — $29

  • 1 fiscal year of pay, line by line
  • 3 equity grants, each cited to its filing
  • IRWD’s disclosed peer group of 17 companies

A PDF and a CSV sent to your email. Every row is cited to its filing.

One-time report. No refunds.

See an example →

Velarion Intel · free for 3 days · no card

See how IRONWOOD PHARMACEUTICALS’s whole pay program stands against its peers

  • IRONWOOD PHARMACEUTICALS’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on IRWD→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 26, 2019 (DEF 14A).

Free

Get William Huyett’s full pay file as a PDF — free

More than this page: up to 10 years of William’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

William Huyett compensation by year

IRONWOOD PHARMACEUTICALS Summary Compensation Table · the one fiscal year held
In US dollars, as IRONWOOD PHARMACEUTICALS reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2018
Salary$465,000
Bonus$0
Stock awards$1,090,298
Option awards$2,346,469
Non-equity incentive$232,500
Pension and deferred compensation$0
All other$8,040
Total$4,142,307

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: IRONWOOD PHARMACEUTICALS INC DEF 14A filed April 26, 2019, accession 0001047469-19-002641, and prior-year filings. Open the filing on EDGAR.

How this page was built: the IRONWOOD PHARMACEUTICALS INC filed document, accession 0001047469-19-002641. Every figure is read from that document and cited to the page and table it appears in. Filed April 26, 2019.

Equity holdings

unvested awards at FY2018 year-end
TypeUnvested unitsValue at year-endExercise price
RSU54,187$561,377—
Option253,125—$15.27

Per the Outstanding Equity Awards at Fiscal Year-End table in IRONWOOD PHARMACEUTICALS INC's FY2018 proxy; value at the fiscal year-end close, as the company printed it.

IRONWOOD PHARMACEUTICALS’s named executive officers, FY2018

as the company reported each
Named executive officerRoleFY2018 total
Peter HechtFormer Chief Executive Officer$5,160,116
William Huyett · this pageFormer Chief Operating Officer$4,142,307
Mark CurrieFormer Senior Vice President, Chief Scientific Officer and President of R&D$2,445,420
Thomas McCourtPresident$2,150,622
Halley GilbertFormer Chief Administrative Officer and Senior Vice President, Corporate Development$1,927,757
Gina ConsylmanChief Financial Officer and Senior Vice President$1,914,688

The full IRONWOOD PHARMACEUTICALS compensation record

free company brief

This page is one person within IRONWOOD PHARMACEUTICALS's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the IRONWOOD PHARMACEUTICALS proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are IRONWOOD PHARMACEUTICALS's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

William Huyett's compensation dossier · One-time report. No refunds.